Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists

Recombinant human erythropoietin (rHuEPO) has been used as a performance‐enhancing agent by athletes in a variety of sports. The resulting increase in hematocrit levels leads to increased blood viscosity and can affect blood flow, potentially increasing the athlete's risk of developing health c...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkhoff, Willem A. J., Heuberger, Jules A. A. C., Post, Titiaan E., Gal, Pim, Stuurman, Frederik E., Burggraaf, Jacobus, Cohen, Adam F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308108/
https://www.ncbi.nlm.nih.gov/pubmed/30592183
http://dx.doi.org/10.14814/phy2.13924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308108/
https://www.ncbi.nlm.nih.gov/pubmed/30592183
http://dx.doi.org/10.14814/phy2.13924

Ejemplares similares